Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Brief alcohol intervention in emergency
ISRCTN ISRCTN06650826
ClinicalTrials.gov identifier
Public title Brief alcohol intervention in emergency
Scientific title
Acronym N/A
Serial number at source 3200-067949
Study hypothesis Brief alcohol intervention for hazardous drinkers admitted to the Emergency Department.
Lay summary
Ethics approval Ethics approval received from the Clinical Research Ethics Committe, Faculty of Medicine, University of Lausannedate on the 8th January 2003 (ref: 193/01).
Study design Randomised controlled trial
Countries of recruitment Switzerland
Disease/condition/study domain Hazardous drinkers
Participants - inclusion criteria Consecutive patients aged 18 and over admitted to the Emergency Department from 11 am to 11 pm daily from January 2003 to June 2004.
Participants - exclusion criteria 1. Patients under 18
2. A history of alcohol-related treatment over the last 12 months
3. Did not qualify for hazardous drinking over the last 30 days
4. Were clinically intoxicated
5. Medical condition that precluded a face-to-face interview
Anticipated start date 01/01/2004
Anticipated end date 30/06/2005
Status of trial Completed
Patient information material
Target number of participants 1000
Interventions A single session 15 minutes brief alcohol intervention including six steps:
1. Thank the patient for participation and provide reassurance about confidentiality
2. Provide feedback about patient's alcohol use compared to similar measures for men and women in the Swiss community and ask the patient's opinion of the feedback
3. Ask the patient to explore the pros and cons of his/her alcohol use
4. Use a one to ten scale to explore patient's importance and readiness to change his/her drinking pattern
5. Ask if the patient feels ready to set an objective and provide positive reinforcement about their ability to achieve this objective
6. Give each patient written material including their Alcohol Screen (AUDIT) score, drinking pattern percentiles compared to the Swiss community, and their drinking pattern objectives.

There were two control groups:
1. Control group one completed the two minute lifestyle screener and a 30-minute face-to-face interview including assessment of alcohol use and alcohol-related consequences and a medical history. They were then contacted 12-month later for follow-up
2. Control group two completed the two minute lifestyle screener, signed a consent form and were contacted 12 month later for follow-up

Usual care does not include any intervention regarding alcohol. Alcohol use is generally adressed with a single yes-no question about patients' alcohol use. Neither systematic nor case finding stategies of counseling or referral are conducted routinely.
Primary outcome measure(s) 1. A 20% decrease in number of drinks per week
2. A 20% decrease in monthly binge drinking frequency
3. Number of medical consultations
4. Days hospitalised and days out of work
Secondary outcome measure(s) 1. Drinking quantity
2. Frequency
3. Hazardous drinking consequences
4. Health related quality of life
Sources of funding Swiss National Science Foundation (Switzerland) (ref: 3200-067949)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17565563
Contact name Dr  Jean-Bernard  Daeppen
  Address Mont-Paisible 16
  City/town Lausanne
  Zip/Postcode 1011
  Country Switzerland
  Email jean-bernard.daeppen@chuv.ch
Sponsor Swiss National Science Foundation (Switzerland)
  Address Wildhainweg 2
  City/town Bern
  Zip/Postcode 3001
  Country Switzerland
  Email div3@snf.ch
Date applied 29/05/2006
Last edited 21/09/2007
Date ISRCTN assigned 11/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central